Terns Pharmaceuticals is a clinical-stage biotechnology company developing small-molecule drugs for metabolic and oncology conditions, including obesity and chronic myeloid leukemia.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 31 | New buy | 321,905 | $16,970,832 | 0.2% |
| Louis Bacon / Moore | 56 | New buy | 50,000 | $2,636,000 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.